Please assess the completion status of the following clinical trial:

Trial Title: Plasma Injections Plus Exercise for Patellar Tendinopathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female ≥ 18 and ≤ 50 years of age at Enrollment Visit~* Documentation of a clinical diagnosis of patellar tendinopathy, grade-IIIB Blazina stage, confirmed on ultrasound~* Previously tried an exercise program of at least six weeks duration~* Fluent in official language of study site~* Written informed consent obtained from subject~* Normal values on screening laboratory panels (CBC, PT, PTT, INR, serum creatine, ALT, ALP, AST, bilirubin, albumin)~Exclusion Criteria:~* For women of child-bearing potential, positive pregnancy test at enrollment visit~* Major surgery in the past three months~* Surgery on the symptomatic knee~* Bleeding disorder~* Systemic inflammatory disease~* Arthritis or degenerative knee condition~* Recent fluoroquinolone use~* Subjects who have any requirement for the use of systemic steroids or immunosuppressants~* Subjects who are known to be HIV positive~* Uncooperative patient, or patients who are incapable of following directions or who are predictably unwilling to return for follow-up examinations~* Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 50 Years
- Healthy Volunteers: f

Study Arms:
- Leukocyte-rich Platelet Rish Plasma + exercise (Type: EXPERIMENTAL): Leukocyte-rich PRP injection and a 12 week exercise program.
- Leukocyte-poor Platelet Rich Plasma + exercise (Type: EXPERIMENTAL): Leukocyte-poor PRP injection and a 12 week exercise program.
- Saline + exercise (Type: PLACEBO_COMPARATOR): Saline injection and a 12 week exercise program.

Based on this trial design, predict the completion outcome and termination type (if applicable).